ST
NBSE

Spot Trading’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Spot Trading’s Portfolio NBSE Stock Details NBSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-7
Closed -$28K – 4787
2014
Q2 		$28K Buy
+7
New +$26.4K ﹤0.01% 4083

Other funds holding NBSE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
B
Bailard Foster City, California $4.35B AUM 23.57% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
GBA
Garrison Bradford & Associates New York $88.4M AUM 15.86% 1-Year Est. Return

Spot Trading's NBSE Position: Q3 2014 in Review

Spot Trading sold out of NeuBase Therapeutics, Inc. Common Stock (NBSE) in Q3 2014, closing a stake of 7 shares — an estimated $28K sold.

Spot Trading first reported a position in NBSE in Q2 2014 and held it in 1 quarter. The position peaked at $28K in Q2 2014. 52 funds tracked by Wall St. Rank hold NBSE as of Q3 2014.

  • Spot Trading reported no remaining NeuBase Therapeutics, Inc. Common Stock position as of Q3 2014 after selling out during the quarter.
  • Spot Trading sold 7 NeuBase Therapeutics, Inc. Common Stock shares in Q3 2014, an estimated $28K.
  • Spot Trading first reported a position in NeuBase Therapeutics, Inc. Common Stock in Q2 2014 and held it in 1 quarter.
  • Spot Trading's NeuBase Therapeutics, Inc. Common Stock position peaked at $28K in Q2 2014.
  • 52 funds tracked by Wall St. Rank held NeuBase Therapeutics, Inc. Common Stock as of Q3 2014.

Based on Spot Trading's 13F filing for Q3 2014, filed 13 Nov 2014.